Kodiak Sciences Inc (KOD)
KOD trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$91.63
-7.69% on the day
Market cap
$5.8B
Mid cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | KOD on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001468748 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-12-17 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-28 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 418 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -11.2% |
| 1 month | +145.1% |
| 3 months | +96.0% |
| Year to date | +189.1% |
| 1 year | +596.9% |
| From 52-week high | -19.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IMVT | Immunovant Inc. | $28.71 | -2.61% | $5.9B |
| CGON | CG Oncology Inc. | $62.40 | -1.16% | $5.5B |
| IOVA | Iovance Biotherapeutics Inc. | $14.50 | -0.41% | $6.6B |
| SRRK | Scholar Rock Holding Corporation | $40.52 | -3.39% | $4.9B |
| CRSP | CRISPR Therapeutics AG Common Shares | $50.10 | -2.81% | $4.8B |
| ADPT | Adaptive Biotechnologies Corporation | $25.28 | -1.13% | $4.0B |
| RGEN | Repligen Corporation | $175.42 | +1.69% | $8.6B |
| RLAY | Relay Therapeutics Inc. | $17.36 | -3.45% | $3.8B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier